What type of hypothyroidism is indicated by the presence of anti‑thyroid peroxidase (TPO) antibodies?

TPO Antibodies Indicate Primary Autoimmune (Hashimoto's) Hypothyroidism

The presence of anti-thyroid peroxidase (TPO) antibodies indicates chronic autoimmune thyroiditis (Hashimoto's thyroiditis), which is the most common cause of primary hypothyroidism in iodine-sufficient areas. 1

Understanding the Autoimmune Etiology

TPO antibodies are one of the key serologic markers that characterize autoimmune thyroid disease (AITD). In areas with adequate iodine intake like the United States, chronic autoimmune thyroiditis represents the predominant cause of hypothyroidism, whereas worldwide, iodine deficiency remains the leading cause 1.

Key Diagnostic Features:

• Approximately 75% of patients with chronic autoimmune thyroiditis have elevated anti-thyroid antibody titers 1
• TPO antibodies are significantly associated with hypothyroidism - more so than anti-thyroglobulin antibodies (TgAb) 1
• The presence of TPO antibodies identifies an autoimmune etiology for thyroid dysfunction 2

Clinical Significance and Prognostic Value

TPO antibodies serve as both diagnostic and prognostic markers:

Progression Risk:

• Patients with subclinical hypothyroidism who are TPO antibody-positive progress to overt hypothyroidism at 4.3% per year 1, 2
• This compares to only 2.6% per year in TPO antibody-negative patients 1, 2
• This nearly doubled risk of progression is why professional societies endorse measuring TPO antibodies in subclinical hypothyroidism 1

Pathophysiology:

Autoimmune thyroid disease is characterized by:

• Pathologically: Infiltration of the thyroid with sensitized T lymphocytes 1
• Serologically: Circulating thyroid autoantibodies (TPO, TgAb, TSH receptor antibodies) 1
• Genetically: An inherited defect in immune surveillance leading to abnormal immune regulation 1

When to Measure TPO Antibodies

Based on guideline recommendations 1:

1. Subclinical hypothyroidism - to predict progression risk (Grade B recommendation)
2. Diffuse, firm goiter - to identify autoimmune thyroiditis
3. Nodular thyroid disease with hypothyroidism - to distinguish autoimmune thyroiditis from non-immunologic multinodular goiter (which rarely progresses to hypothyroidism)
4. Documented hypothyroidism - to identify the underlying cause
5. High-risk populations:
   • Patients with other autoimmune diseases (type 1 diabetes, Addison's disease)
   • Chromosomal disorders (Down syndrome, Turner syndrome)
   • Exposure to certain medications (lithium, interferon alpha, amiodarone)

Important Clinical Caveats

Population Prevalence:

• In disease-free populations, TPO antibodies are positive in 11.3% 1
• More common in women than men and increase with age 1
• Autoimmune thyroid disease is 5-10 times more common in women 1

Limitations:

• While TPO antibodies identify autoimmune etiology, their presence or absence does not change the diagnosis of subclinical hypothyroidism (which is based on TSH) or the expected efficacy of treatment 2
• Not all patients with positive TPO antibodies will develop hypothyroidism - only about 10% of those with positive antibodies have hypothyroidism 3
• Once present, these antibodies generally persist, with spontaneous disappearance occurring infrequently 1

Distinguishing Subtypes:

There are two types of autoimmune thyroiditis 3:

1. Goitrous Hashimoto's thyroiditis - associated with TPO/TgAb antibodies
2. Atrophic thyroiditis - associated with TSH-receptor blocking antibodies (TSBAb), causing thyroid atrophy

The key distinction: TPO antibodies specifically indicate Hashimoto's thyroiditis (primary autoimmune hypothyroidism), not secondary hypothyroidism from pituitary or hypothalamic causes, and not other forms of primary hypothyroidism like iodine deficiency or post-ablative hypothyroidism.